Propeller Health Archives | McKesson Ventures

Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform

...

Novartis receives CHMP positive opinion for Enerzair® Breezehaler® (QVM149), a potential first-in-class inhaled LABA/LAMA/ICS combination for uncontrolled asthma

When emissions decrease, people’s asthma gets better

Digital therapeutics company SidekickHealth inks partnership with Bayer

Express Scripts unveiled the first group of digital therapeutics included in its digital health formulary

Walgreens offers new tool for chronic care management

Inhaler Monitoring Cuts Hospitalization Usage, Study Finds

Propeller Health’s new deal with Orion Corporation extends its European reach

M&A Analysis: 10 Reasons Why ResMed Acquired Propeller Health for $225M

Asthma-related ER visits decline by more than half for patients using digitally connected inhalers

1
2